Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data from its Phase 2a clinical ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Araceli Biosciences, a pioneering biotechnology company revolutionizing high-content imaging and AI-powered analysis, today ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

A new Cambridge biotech is creating a roadmap to expand preventive health to a broader range of diseases, treating patients ...

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

The piece of lab-grown meat had an artificial circulatory system of hollow fibers delivering nutrients and oxygen.